- Home
- BFLY vs CELC Comparison
BFLY vs CELC Comparison
Compare BFLY & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFLY
- CELC
- Stock Information
- Founded
- BFLY 2011
- CELC 2011
- Country
- BFLY United States
- CELC United States
- Employees
- BFLY N/A
- CELC N/A
- Industry
- BFLY Medical Electronics
- CELC Medical Specialities
- Sector
- BFLY Health Care
- CELC Health Care
- Exchange
- BFLY Nasdaq
- CELC Nasdaq
- Market Cap
- BFLY 506.9M
- CELC 440.0M
- IPO Year
- BFLY N/A
- CELC 2017
- Fundamental
- Price
- BFLY $1.76
- CELC $13.78
- Analyst Decision
- BFLY Strong Buy
- CELC Strong Buy
- Analyst Count
- BFLY 3
- CELC 6
- Target Price
- BFLY $3.50
- CELC $30.67
- AVG Volume (30 Days)
- BFLY 4.9M
- CELC 210.9K
- Earning Date
- BFLY 07-31-2025
- CELC 08-13-2025
- Dividend Yield
- BFLY N/A
- CELC N/A
- EPS Growth
- BFLY N/A
- CELC N/A
- EPS
- BFLY N/A
- CELC N/A
- Revenue
- BFLY $85,625,000.00
- CELC N/A
- Revenue This Year
- BFLY $21.09
- CELC N/A
- Revenue Next Year
- BFLY $25.79
- CELC N/A
- P/E Ratio
- BFLY N/A
- CELC N/A
- Revenue Growth
- BFLY 25.77
- CELC N/A
- 52 Week Low
- BFLY $0.90
- CELC $7.58
- 52 Week High
- BFLY $4.98
- CELC $19.77
- Technical
- Relative Strength Index (RSI)
- BFLY 30.42
- CELC 63.64
- Support Level
- BFLY $1.85
- CELC $13.35
- Resistance Level
- BFLY $1.98
- CELC $14.50
- Average True Range (ATR)
- BFLY 0.09
- CELC 0.74
- MACD
- BFLY -0.01
- CELC 0.06
- Stochastic Oscillator
- BFLY 9.23
- CELC 75.88
About BFLY Butterfly Network Inc.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. The company enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.